Medicine Man Technologies (SHWZ)
OTHER OTC:SHWZ
Holding SHWZ?
Track your performance easily

Medicine Man Technologies (SHWZ) Income Statement

143 Followers

Medicine Man Technologies Income Statement

Last quarter (Q3 2023), Medicine Man Technologies's total revenue was $42.94M, an increase of 8.77% from the same quarter last year. In Q3, Medicine Man Technologies's net income was $-1.87M. See Medicine Man Technologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 119.65M$ 172.45M$ 142.95M$ 116.93M$ 26.59M$ -325.59K
Credit Losses Provision
-----$ 151.17K
Non Interest Expense
$ 77.90M-$ 72.17M$ 38.94M$ 46.90M$ 29.48M
Incomefrom Associatesand Other Participating Interests
------
Special Income Charges
$ -10.97M$ -1.80M$ -8.01M$ -59.07M$ -17.23M$ -7.62M
Pretax Income
$ -13.64M$ -14.81M$ -3.57M$ 18.92M$ -20.32M$ -17.56M
Tax Provision
$ 18.89M$ 19.74M$ 14.90M$ 4.40M$ -899.11K$ -582.93K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -40.96M$ -42.70M$ -26.27M$ 7.17M$ -19.42M$ -16.98M
Basic EPS
$ -0.59$ -0.66$ -0.49$ 0.17$ -0.47$ -0.50
Diluted EPS
$ 0.24$ -0.66$ -0.49$ -0.06$ -0.47$ -0.50
Basic Average Shares
$ 270.87M$ 64.54M$ 53.64M$ 43.34M$ 41.22M$ 33.74M
Diluted Average Shares
$ 192.46M$ 64.54M$ 53.64M$ 101.37M$ 41.22M$ 33.74M
Dividend Per Share
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Interest Income After Provision For Loan Loss
$ -30.80M-$ -30.14M$ -7.01M$ -41.46K$ -311.36K
Net Income From Continuing And Discontinued Operation
$ -32.52M$ -34.55M$ -18.47M$ 14.52M$ -19.42M$ -16.98M
Normalized Income
$ 7.95M-$ 9.88M$ 14.70M--
Total Money Market Investments
------
Ebit
-$ 17.26M----
Ebitda
-$ 48.40M----
Currency in USD

Medicine Man Technologies Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis